Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9121 - 9128 of 12089 results
Legislative Roundup on Energy from the New England States
September 17, 2015| Blog| Viewpoint
NJ Appellate Court Offers New Guidance on Employee Arbitration Agreements
September 17, 2015| Blog| Viewpoint
Senators to Receive Update on Biosimilar Implementation from CDER’s Woodcock
September 17, 2015| Blog| Viewpoint
The Basics of EB-5 Financing in a Transaction: Treat Your EB-5 Deal like an IPO [VIDEO]
September 16, 2015| Blog| Viewpoint
CPSC Suspends Over 90% of $3.5 Million Civil Penalty Due to Company’s Inability to Pay; phil&teds USA to Pay $200,000
September 16, 2015| Blog| Viewpoint
U.S. Courts Continue to Deny Attempts to Bring Foreign Law Actions in U.S. Courts to Recover for Potential Losses in Foreign Transactions
September 16, 2015| Blog| Viewpoint
What questions should executives ask about their D&O insurance following the new DOJ policies?
September 16, 2015| Blog| Viewpoint
Medicare to Permit Value-Based Insurance Design in Medicare Advantage Plans
September 16, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|